Pericarditis in systemic lupus erythematosus: a series of clinical cases

Systemic lupus erythematosus (SLE) is a chronic autoimmune disease characterized by polysyndromic lesions of various organs and systems. Clinical manifestations of SLE may include lesions of the skin, joints, kidneys, serous membranes, and hematopoiesis system, which significantly complicates the diagnosis and management of patients. This paper presents three clinical cases demonstrating the variety of manifestations and severity of the course of SLE. In the first case, the disease debuted with a massive hydropericardium, which required surgical intervention. In the second case, the patient was observed for a long time with autoimmune nephritis, but later developed pulmonary embolism, which required correction of therapy. The third case was characterized by high activity of the disease with polyserositis, pancytopenia and severe skin manifestations, which required the use of genetically engineered biological therapy (GIBP). In the presented cases, a comprehensive examination of patients was performed, including immunological markers, instrumental diagnostic methods (CT, ECHO-CS, biopsy), as well as a differential diagnosis with hemoblastosis, vasculitis and other systemic diseases. The treatment was based on glucocorticosteroids (GCS), cytostatics (cyclophosphamide) and biological therapy (rituximab), which made it possible to stabilize the condition of patients and reduce the activity of the disease. Thus, the presented clinical cases illustrate the significant variety of clinical manifestations and the complexity of the diagnosis of SLE, which emphasizes the need for a multidisciplinary approach to the management of such patients. Modern therapies, including GIBP, make it possible to control the activity of the disease and improve the prognosis of patients with severe forms of SLE.

Authors

Institutions

Publication Details

Journal
South Russian Journal of Therapeutic Practice
Published
2025-07-12
DOI
https://doi.org/10.21886/2712-8156-2025-6-2-80-86
Primary Topic
Systemic Lupus Erythematosus Research
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Pericarditis in systemic lupus erythematosus: a series of clinical cases

А. М. Намитоков, С. В. Кручинова, E. D. Kosmacheva, V. E. Dzhodzhua et al.
South Russian Journal of Therapeutic Practice
Systemic Lupus Erythematosus Research
article

Pericarditis in systemic lupus erythematosus: a series of clinical cases

А. М. Намитоков, С. В. Кручинова, E. D. Kosmacheva, V. E. Dzhodzhua, N. A. Nikulshin
article en

Abstract

Systemic lupus erythematosus (SLE) is a chronic autoimmune disease characterized by polysyndromic lesions of various organs and systems. Clinical manifestations of SLE may include lesions of the skin, joints, kidneys, serous membranes, and hematopoiesis system, which significantly complicates the diagnosis and management of patients. This paper presents three clinical cases demonstrating the variety of manifestations and severity of the course of SLE. In the first case, the disease debuted with a massive hydropericardium, which required surgical intervention. In the second case, the patient was observed for a long time with autoimmune nephritis, but later developed pulmonary embolism, which required correction of therapy. The third case was characterized by high activity of the disease with polyserositis, pancytopenia and severe skin manifestations, which required the use of genetically engineered biological therapy (GIBP). In the presented cases, a comprehensive examination of patients was performed, including immunological markers, instrumental diagnostic methods (CT, ECHO-CS, biopsy), as well as a differential diagnosis with hemoblastosis, vasculitis and other systemic diseases. The treatment was based on glucocorticosteroids (GCS), cytostatics (cyclophosphamide) and biological therapy (rituximab), which made it possible to stabilize the condition of patients and reduce the activity of the disease. Thus, the presented clinical cases illustrate the significant variety of clinical manifestations and the complexity of the diagnosis of SLE, which emphasizes the need for a multidisciplinary approach to the management of such patients. Modern therapies, including GIBP, make it possible to control the activity of the disease and improve the prognosis of patients with severe forms of SLE.

South Russian Journal of Therapeutic PracticeVol. 6(2)
Kuban State Medical University (RU), Regional Clinical Research (US)
Openalex Percentile: Top 72%
Systemic Lupus Erythematosus Research
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.